Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

We now have two FDA-approved disease-modifying treatments for Alzheimer's disease, and hundreds of clinical trials are ...

Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone ...

LATE is a prevalent condition in late life and can contribute to memory loss and cognitive decline, according to report ...

New research suggests that commonly used medications like antibiotics, antivirals, and anti-inflammatories could lower the ...

Three common heart conditions—heart failure, atrial fibrillation, and coronary heart disease—are closely linked to cognitive decline and a higher risk of dementia, according to a new scientific ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...

Repurposing existing drugs, including antibiotics, antivirals, and vaccines, may offer a promising strategy for combating ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...